The document discusses the changing role of pharmacists and the benefits of integrating pharmacists into medical teams. It presents several studies that show pharmacists improving clinical outcomes when involved in patient care. The rationale is that pharmacists can help physicians optimize drug therapy and patient safety by providing expertise in areas like monitoring treatments, detecting interactions and adverse reactions, and managing costs. The conclusion is that applying pharmaceutical care principles can both improve health outcomes and reduce healthcare costs.
This document discusses the development of clinical pharmacy and pharmaceutical care as disciplines and proposes a new discipline called clinical pharmaceutical care. It notes that while clinical pharmacy and pharmaceutical care have benefits, they also have some limitations in fully achieving patient care goals. The proposed new discipline of clinical pharmaceutical care would combine principles of management, information and communication technologies, and clinical pharmacy practice to better coordinate care, prioritize patients, and improve clinical and economic outcomes. The article encourages recognition of clinical pharmaceutical care by international organizations and inclusion of its principles in pharmacy education programs.
This article discusses the need for clinical pharmacists to develop skills in areas like communication, problem-solving, and emotional intelligence in order to effectively contribute as members of multidisciplinary medical teams. It analyzes the curricula of pharmacy programs and finds that courses focusing specifically on building these behavioral skills are lacking. The article argues that incorporating training on psychological and behavioral aspects would allow clinical pharmacists to better provide pharmaceutical care services and improve patient outcomes through collaborative work with other healthcare professionals. Universities are urged to include dedicated coursework on developing these types of soft skills to prepare pharmacists for patient-centered practice.
The document summarizes the historical development of clinical pharmacy and pharmaceutical care from 1928 to 2016. It outlines key steps such as pharmacists beginning to participate in patient rounds in 1928. It also reviews studies showing the positive impact of clinical pharmacists on patient outcomes when included as part of the medical team. This includes reduced mortality, readmission rates, and healthcare costs. The conclusion is that incorporating clinical pharmacy expertise into medical care through a flexible team-based approach is essential for improving clinical outcomes, especially with new complex drug formulations.
The document appears to be an abstract for a poster presentation at a conference in Milano, Italy in 2016. It likely provided a brief overview of the topic that would be discussed in more depth through the poster. Unfortunately, without more context or the full text of the abstract, only a high-level 3 sentence summary can be generated.
The document discusses the changing role of pharmacists and the benefits of integrating pharmacists into medical teams. It presents several studies that show pharmacists improving clinical outcomes when involved in patient care. The rationale is that pharmacists can help physicians optimize drug therapy and patient safety by providing expertise in areas like monitoring treatments, detecting interactions and adverse reactions, and managing costs. The conclusion is that applying pharmaceutical care principles can both improve health outcomes and reduce healthcare costs.
This document discusses the development of clinical pharmacy and pharmaceutical care as disciplines and proposes a new discipline called clinical pharmaceutical care. It notes that while clinical pharmacy and pharmaceutical care have benefits, they also have some limitations in fully achieving patient care goals. The proposed new discipline of clinical pharmaceutical care would combine principles of management, information and communication technologies, and clinical pharmacy practice to better coordinate care, prioritize patients, and improve clinical and economic outcomes. The article encourages recognition of clinical pharmaceutical care by international organizations and inclusion of its principles in pharmacy education programs.
This article discusses the need for clinical pharmacists to develop skills in areas like communication, problem-solving, and emotional intelligence in order to effectively contribute as members of multidisciplinary medical teams. It analyzes the curricula of pharmacy programs and finds that courses focusing specifically on building these behavioral skills are lacking. The article argues that incorporating training on psychological and behavioral aspects would allow clinical pharmacists to better provide pharmaceutical care services and improve patient outcomes through collaborative work with other healthcare professionals. Universities are urged to include dedicated coursework on developing these types of soft skills to prepare pharmacists for patient-centered practice.
The document summarizes the historical development of clinical pharmacy and pharmaceutical care from 1928 to 2016. It outlines key steps such as pharmacists beginning to participate in patient rounds in 1928. It also reviews studies showing the positive impact of clinical pharmacists on patient outcomes when included as part of the medical team. This includes reduced mortality, readmission rates, and healthcare costs. The conclusion is that incorporating clinical pharmacy expertise into medical care through a flexible team-based approach is essential for improving clinical outcomes, especially with new complex drug formulations.
The document appears to be an abstract for a poster presentation at a conference in Milano, Italy in 2016. It likely provided a brief overview of the topic that would be discussed in more depth through the poster. Unfortunately, without more context or the full text of the abstract, only a high-level 3 sentence summary can be generated.
This document discusses velocity management strategy and its potential applications in healthcare. Velocity management uses time management tools and techniques from fields like the military to rapidly achieve goals and improve business results by 30-40%. It argues that velocity management skills should be added to management education curriculums. Applying these strategies in healthcare through tools like social media, data sharing, and new technologies could reduce global healthcare costs by 30% in areas like ICUs and toxicology. Velocity management's focus on quick decision-making and constant communication could help healthcare managers adapt to today's fast-paced, global competitive environment.
This document summarizes and discusses several journal articles on oncologic drug therapy and clinical trials. It notes that while improved survival is the gold standard for proving clinical benefit, surrogate endpoints like tumor shrinkage are often used. However, studies have not consistently shown tumor response correlates with survival for some cancers. It also discusses challenges with targeted therapies that are cytostatic not cytotoxic, and how some patients may benefit from disease stabilization. The document questions if new rules are needed for clinical trials and drug approvals to better evaluate emerging immunotherapies and targeted therapies.
This document proposes a new social media model to help lower and middle classes during economic crises. It suggests that a targeted social network or search engine could provide users with resources and assistance for everyday needs like work, education, banking, and healthcare. By changing algorithms to prioritize lower costs and better conditions, the tool could help users reduce total costs by up to 70%. The author argues this new model represents a major market opportunity to support economically vulnerable groups through sharing principles and independent, verified information on the social media platform.
This research article discusses how professional social media can help connect researchers in a more rapid way. It analyzes data on the percentage of health care professionals and hospitals using social media. Professional social media networks allow researchers to post profiles, publications, and interests to connect with others in their field from around the world. While some sites publish untrusted information, social media and databases like PubMed and LinkedIn provide a way to quickly find articles and meet other professionals and researchers.
The document discusses the relationship between amygdala dysfunction and criminal or aggressive behavior. It reviews studies showing amygdala activation is involved in behaviors like anger, anxiety, fear and aggression. The amygdala is connected to other brain regions implicated in emotional processing and moral behavior. Neuroimaging studies of violent offenders and those with psychopathy or antisocial personality disorder show amygdala abnormalities. The paper argues we need objective ways to diagnose pathological amygdala activation levels and determine if drug therapies could treat amygdala dysfunctions, potentially helping to prevent some criminal behaviors. Further research is needed to better understand the links between amygdala function, aggression and crime.
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive functioning. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms.
This document lists publications by M. Luisetto from 2016-2017, including:
1) A research article in the International Journal of Economics & Management Sciences on using social media to connect researchers and healthcare professionals.
2) An editorial in the Journal of Business & Financial Affairs on a new healthcare management strategy called "velocity management" to reduce costs.
3) A research article in the Journal of Business & Financial Affairs on synergies between clinical pharmaceutical care, medical imaging, and nuclear medicine to efficiently lower healthcare costs.
This document discusses velocity management strategy and its potential applications in healthcare. Velocity management uses time management tools and techniques from fields like the military to rapidly achieve goals and improve business results by 30-40%. It argues that velocity management skills should be added to management education curriculums. Applying these strategies in healthcare through tools like social media, data sharing, and new technologies could reduce global healthcare costs by 30% in areas like ICUs and toxicology. Velocity management's focus on quick decision-making and constant communication could help healthcare managers adapt to today's fast-paced, global competitive environment.
This document summarizes and discusses several journal articles on oncologic drug therapy and clinical trials. It notes that while improved survival is the gold standard for proving clinical benefit, surrogate endpoints like tumor shrinkage are often used. However, studies have not consistently shown tumor response correlates with survival for some cancers. It also discusses challenges with targeted therapies that are cytostatic not cytotoxic, and how some patients may benefit from disease stabilization. The document questions if new rules are needed for clinical trials and drug approvals to better evaluate emerging immunotherapies and targeted therapies.
This document proposes a new social media model to help lower and middle classes during economic crises. It suggests that a targeted social network or search engine could provide users with resources and assistance for everyday needs like work, education, banking, and healthcare. By changing algorithms to prioritize lower costs and better conditions, the tool could help users reduce total costs by up to 70%. The author argues this new model represents a major market opportunity to support economically vulnerable groups through sharing principles and independent, verified information on the social media platform.
This research article discusses how professional social media can help connect researchers in a more rapid way. It analyzes data on the percentage of health care professionals and hospitals using social media. Professional social media networks allow researchers to post profiles, publications, and interests to connect with others in their field from around the world. While some sites publish untrusted information, social media and databases like PubMed and LinkedIn provide a way to quickly find articles and meet other professionals and researchers.
The document discusses the relationship between amygdala dysfunction and criminal or aggressive behavior. It reviews studies showing amygdala activation is involved in behaviors like anger, anxiety, fear and aggression. The amygdala is connected to other brain regions implicated in emotional processing and moral behavior. Neuroimaging studies of violent offenders and those with psychopathy or antisocial personality disorder show amygdala abnormalities. The paper argues we need objective ways to diagnose pathological amygdala activation levels and determine if drug therapies could treat amygdala dysfunctions, potentially helping to prevent some criminal behaviors. Further research is needed to better understand the links between amygdala function, aggression and crime.
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive functioning. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms.
This document lists publications by M. Luisetto from 2016-2017, including:
1) A research article in the International Journal of Economics & Management Sciences on using social media to connect researchers and healthcare professionals.
2) An editorial in the Journal of Business & Financial Affairs on a new healthcare management strategy called "velocity management" to reduce costs.
3) A research article in the Journal of Business & Financial Affairs on synergies between clinical pharmaceutical care, medical imaging, and nuclear medicine to efficiently lower healthcare costs.
APPR.MS.ID.000579.pdf NON STERILE GALENIC LABORATORY 2024 luisetto m et al
Studio farmaceutico di consulenza e pharmaceutical care dir. 2013 55 ue N. 72
1. Modifica direttiva 2005/36 direttiva 2013 55 UE
Rientrano nelle competenze professionali del farmacista a livello europeo:
Art. 45 punto g) g) diffusione di informazioni e di consigli sui medicinali in quanto tali,
compreso il loro uso corretto;
(riconoscimento giuridico ufficiale per inserimento della pharmaceutical care tra i campi
d’intervento propri del farmacista.)